Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study

Fig. 1

Associations between skin AF and glycemic status in the EPIC-DZD study. N = 3535. Glycemic status was defined as follows: normoglycemic (HbA1c < 5.7% and no antidiabetic treatment), prediabetes (6.5% > HbA1c ≥ 5.7% and no antidiabetic treatment), diabetes (antidiabetic treatment, HbA1c ≥ 6.5% or prevalent diabetes at EPIC-Potsdam baseline). Differences in medians of skin AF were compared with 1-way ANOVA with Tukey–Kramer’s correction for multiple testing. Linear trend in skin AF across glycemic strata was assessed with linear regression. AF autofluorescence, HbA1c glycated hemoglobin 1C

Back to article page